Compare Bank Artha Graha Internasional Tbk. (INPC) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank Artha Graha Internasional Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Bank Artha Graha Internasional Tbk. trades at Rp160 (market cap 3.26T, 5.45M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Bank Artha Graha Internasional Tbk. is far larger — about 31.2× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| INPC | SCPI | |
|---|---|---|
Market Cap | 3.26T | 104.4B |
Volume | 5.45M | — |
Lot | 54.46K | — |
Turnover | 868.19M | — |
Average Price | 159.41 | — |
Value | 868.19M | — |
Indicative Equilibrium Price | 160 | — |
Indicative Equilibrium Volume | 402 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bank Artha Graha Internasional Tbk.
PT Bank Artha Graha Internasional Tbk (“the Bank”) initially was established under the name of PT Inter-Pacific Financial Corporation based on notarial deed No. 12 dated September 7, 1973 of Bagijo, SH, substitute notary of Eliza Pondaag, SH, Notary in Jakarta. PT Bank Inter Pacific, Tbk is a joint venture bank that for the previous period of 20 years operated as Non Bank Financial Institution (NBFI) and went public in August 1990.
Read more on INPC →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
